• Home
  • Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice.

Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice.

Author List
Chang T, Krisman K, Theobald EH, Xu J, Akutagawa J, Lauchle JO, Kogan S, Braun BS, Shannon K
Publication
The Journal of clinical investigation
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1196654
Publication Year
2016
PubMed ID
26727232
Publication Title
Chang T, Krisman K, Theobald EH, Xu J, Akutagawa J, Lauchle JO, Kogan S, Braun BS, Shannon K. Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice. J Clin Invest. 2016 Jan; 126(1):404.